| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $893K | +1075.0% |
| R&D Expense | $114.1M | -10.6% |
| SG&A Expense | $51.8M | -7.7% |
| Operating Income | -$165.0M | +10.2% |
| Interest Expense | $4K | -55.6% |
| Pre-tax Income | -$151.2M | +7.8% |
| Income Tax | $414K | +169.2% |
| Net Income | -$69.0M | -12.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.5M | +9.5% |
| Current Assets | $280.7M | -29.1% |
| Total Assets | $335.6M | -23.9% |
| Current Liabilities | $30.7M | -15.1% |
| Total Liabilities | $34.8M | -11.8% |
| Stockholders' Equity | -$1.01B | -1.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$120.1M | +4.9% |
| Capital Expenditures | $15.2M | -48.5% |
| Investing Cash Flow | $104.0M | +409.3% |
| Financing Cash Flow | $25.6M | -82.3% |
| Free Cash Flow | -$135.3M | +13.2% |